LC-Plasma on Immune Response and Reducing Symptoms of Upper Respiratory Infectious Diseases

Authors
Category Primary study
Registry of TrialsClinicalTrials.gov
Year 2025
The goal of this study is to evaluate the effects of LC-Plasma on the innate and acquired immune systems, including the activation of pDCs, which play a role in virus elimination, as well as to assess its efficacy in reducing clinical symptoms of upper respiratory infectious diseases in healthy adults. Researchers will compare LC-Plasma to placebo, participants will take a tablet containing LC-Plasma or placebo daily for 4 weeks.
Epistemonikos ID: 64e0da6fa90829d33ba7b6b614dba4b4ed87b72c
First added on: Mar 01, 2025